BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 6609771)

  • 1. The effect of beta-lactamase stability, penetration, and target affinity on the activity of cefazolin, cefamandole, cefoxitin, and cefuroxime.
    Harper PB
    Clin Ther; 1984; 6(3):310-24. PubMed ID: 6609771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The activity of cephalosporins on beta-lactamase-producing Neisseria gonorrhoeae.
    Phillips I; Shannon K
    Scand J Infect Dis Suppl; 1978; (13):23-6. PubMed ID: 98833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Moxalactam and cefotaxime--two new beta-lactam antibiotics compared with three well-known cephalosporins].
    Baumgärtner M; Dickgiesser N; Müller S; Wundt W
    Arzneimittelforschung; 1981; 31(10):1677-81. PubMed ID: 6274361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [3 new cephalosporins: cefamandole, cefuroxime, cefoxitin].
    Mirimanoff RO; Héraïef E
    Rev Med Suisse Romande; 1981 Dec; 101(12):963-8. PubMed ID: 7342276
    [No Abstract]   [Full Text] [Related]  

  • 5. [Activity of new cephalosporins against polyresistant bacterial strains].
    De Toffoli A; Fantin B
    Minerva Med; 1983 Mar; 74(9-10):427-31. PubMed ID: 6300736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinico-microbiologic bases for the use of new cephalosporins].
    De Bac C; Mascellino MT; Nuti M
    Minerva Med; 1982 Apr; 73(15):899-903. PubMed ID: 6979006
    [No Abstract]   [Full Text] [Related]  

  • 7. Newer cephalosporins and cephamycins--a review.
    Norrby R
    Scand J Infect Dis Suppl; 1978; (13):83-7. PubMed ID: 356183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro bactericidal action of cefoperazone, cefoxitin, cefuroxime, cefazolin and cephaloridine.
    Piantieri G; Cafarelli A; Magliulo E
    G Batteriol Virol Immunol; 1981; 74(1-6):15-25. PubMed ID: 6458524
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative in-vitro activity of cefamandole, cefoxitin, cefuroxime and cephalothin.
    Brorson JE; Norrby R
    Scand J Infect Dis Suppl; 1978; (13):88-93. PubMed ID: 278150
    [No Abstract]   [Full Text] [Related]  

  • 10. Correlation of beta-lactamase stability and antibacterial activity of beta-lactams in beta-lactamase-producing bacteria and respective transconjugants.
    Esposito S; Galante D; Barba D; Pennucci C; Limauro D
    Drugs Exp Clin Res; 1986; 12(4):329-33. PubMed ID: 3522155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of in vitro susceptibility with in vivo efficacy in mice for cefoxitin in comparison with cephalosporins.
    Miller AK; Celozzi E; Pelak BA; Birnbaum J; Stapley EO
    J Antimicrob Chemother; 1979 Sep; 5(5):569-79. PubMed ID: 315403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial evaluation of cefoxitin: a new semisynthetic cephamycin. Comparative studies with cefazolin and cefalotin.
    Une T; Mitsuhashi S
    Arzneimittelforschung; 1977; 27(1):89-93. PubMed ID: 576821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cefoxitin, a new beta-lactamase stable antibiotic].
    Simon C; Meyer E; Malerczyk
    Arzneimittelforschung; 1978; 28(9):1541-5. PubMed ID: 314296
    [No Abstract]   [Full Text] [Related]  

  • 14. Methodological implications of testing anaerobe susceptibility to cephalosporins (cefazolin, cefamandole, cefoxitin).
    Krasemann C; Werner H; Hildenbrand G; Benning M; Brandt U; Ungerechts J
    Infection; 1980; 8 Suppl 2():S182-6. PubMed ID: 6969693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The in vitro spectrum of the cephalosporins.
    Washington JA
    Mayo Clin Proc; 1976 Apr; 51(4):237-50. PubMed ID: 1263595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro and in vivo antimicrobial activity of cefuroxime cefamandole and cephalexin on freshly isolated strains of Gram-positive and Gram-negative bacteria].
    Piccolomini R; Arpini A; Di Sipio L; Minelli G
    Boll Soc Ital Biol Sper; 1981 Jul; 57(13):1450-6. PubMed ID: 7284112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of cefoxitin and parenterally administered cephalosporins against anaerobic bacteria.
    Sutter VL; Kirby B; Finegold SM
    Rev Infect Dis; 1979; 1(1):218-23. PubMed ID: 318226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further comparisons between cefuroxime and cefamandole in its in vitro activity.
    Bergström S; Normark S
    Scand J Infect Dis Suppl; 1980; suppl 25():30-1. PubMed ID: 7010538
    [No Abstract]   [Full Text] [Related]  

  • 19. ["In vitro" activity of cefamandole, cefalotin, cefoxitin and cefuroxim against enterobacteria and Staphylococcus aureus isolated in hospital (author's transl)].
    Thabaut A; Durosoir JL; Saliou P
    Pathol Biol (Paris); 1979 Dec; 27(10):649-54. PubMed ID: 395496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefuroxime, cefamandole, cefoxitin, and cephalothin in vitro susceptibility tests: reassessment of the "class representative" concept, confirmation of disk interpretive criteria, and proposed quality control guidelines.
    Barry AL; Jones RN; Thornsberry C
    Am J Clin Pathol; 1983 Aug; 80(2):182-9. PubMed ID: 6881092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.